Case Reports: Late Emergence of Cutaneous Leishmaniasis in an Immunocompromised Patient in a Non-Endemic Setting

David New; Benjamin A Rogers

doi:10.4269/ajtmh.18-0617

Case Reports: Late Emergence of Cutaneous Leishmaniasis in an Immunocompromised Patient in a Non-Endemic Setting

Am J Trop Med Hyg. 2019 Jan;100(1):115-116. doi: 10.4269/ajtmh.18-0617.

Authors

David New¹, Benjamin A Rogers^{2

1}

Affiliations

¹ Infectious Diseases Department, Monash Health, Melbourne, Australia.
² Monash Centre for Inflammatory Diseases, Monash University, Melbourne, Australia.

Abstract

We report a case of reactivation of cutaneous leishmaniasis caused by Leishmania major in a 40-year-old man from Afghanistan, in the context of immune suppression. His last potential exposure was 7 years before the clinical presentation. To our knowledge, this is the most temporally distant reactivation of cutaneous leishmaniasis reported in a non-endemic country.

Publication types

Case Reports

MeSH terms

Adult
Afghanistan
Antiprotozoal Agents / therapeutic use
Australia
Biopsy
DNA, Ribosomal Spacer / genetics
Humans
Immunocompromised Host*
Immunosuppression Therapy / adverse effects
Leishmania major / genetics
Leishmania major / isolation & purification*
Leishmaniasis, Cutaneous / diagnosis*
Leishmaniasis, Cutaneous / drug therapy
Male
Phosphorylcholine / analogs & derivatives
Phosphorylcholine / therapeutic use
Skin / pathology
Treatment Outcome

Substances

Antiprotozoal Agents
DNA, Ribosomal Spacer
Phosphorylcholine
miltefosine